NASHVILLE--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced two oral presentations and one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results